Welcome to our dedicated page for Waters news (Ticker: WAT), a resource for investors and traders seeking the latest updates and insights on Waters stock.
Waters Corporation (NYSE: WAT) is a global leader in the field of analytical instruments and software solutions. For nearly six decades, the company has pioneered advancements in chromatography, mass spectrometry, and thermal analysis, catering to life, materials, and food sciences. Headquartered in Milford, Massachusetts, Waters Corp. operates directly in 35 countries, supported by approximately 8,000 employees and 15 manufacturing facilities globally.
Waters' main business segments include Waters, TA Instruments, VICAM, ERA, and Nonlinear Dynamics. The company's diverse product portfolio features ultra-performance liquid chromatography (UPLC), high-performance liquid chromatography (HPLC), chromatography columns, mass spectrometry systems, and laboratory informatics solutions. These innovations empower laboratory-dependent organizations to achieve advancements in healthcare, environmental management, food safety, and water quality.
Waters Corporation serves a wide array of customers, including biopharmaceutical companies (57% of sales), industrial clients (31% of sales), and academic/government institutions (12% of sales). The company’s products are available in over 100 countries, ensuring a broad market reach.
Recent achievements include the launch of new accessories for TA Instruments Discovery Hybrid Rheometers, designed for battery formulation analysis, and the introduction of Oasis WAX/GCB and GCB/WAX Cartridges for PFAS analysis. These innovations reflect the company’s commitment to addressing emerging scientific challenges and regulatory requirements. Additionally, Waters continues to enhance its mass spectrometry capabilities with products like the ACQUITY QDa II Mass Detector and the Xevo MRT MS, aimed at accelerating research in pharmaceuticals, food, chemicals, and materials.
Financially, Waters Corporation reported first-quarter 2024 sales of $637 million, with a strategic focus on innovation and operational efficiency. Despite a 7% decrease in sales compared to the previous year, the company remains optimistic about future growth, driven by new product launches and higher growth areas.
Waters Corporation stands as a pivotal player in the analytical instruments industry, consistently driving scientific advancements and operational excellence.
Waters Corporation (NYSE:WAT) will announce its Q1 2023 financial results on May 9, 2023, at 8:00 a.m. Eastern Time. A live webcast will be accessible through the company’s investor relations website, with a replay available until May 23, 2023. Waters Corporation has a rich history of over 60 years in analytical instruments, including chromatography and mass spectrometry, and operates in more than 35 countries with over 8,200 employees globally.
Waters Corporation (NYSE:WAT) has launched the Xevo TQ Absolute IVD System, enhancing its MassTrak IVD portfolio. This state-of-the-art system is the most sensitive benchtop tandem quadrupole mass spectrometer for clinical applications, boasting up to five times the sensitivity of its peers. It features a 45% smaller design and consumes 50% less nitrogen gas and electricity, making it environmentally sustainable. The Xevo TQ Absolute IVD allows laboratories to analyze trace-level analytes in smaller samples, thereby expanding testing capabilities for less-invasive assays. The system aims to improve patient care through advanced diagnostic options.
Waters Corporation (NYSE:WAT) has appointed Richard Fearon to its Board of Directors, effective March 27, 2023. Fearon, former Vice Chairman and Chief Financial Officer of Eaton Corporation, is expected to bring financial expertise and strategic development skills to enhance Waters' growth plan. CEO Udit Batra noted that Fearon's leadership experience will strengthen Waters' competitive position. This change follows the retirement of Edward Conard, who has served on the board since 1994, contributing to an 80-fold stock increase over nearly 30 years. The board will now consist of nine members, with three new appointees over the past year.
Waters Corporation (NYSE:WAT) has launched its Alliance iS High Performance Liquid Chromatography (HPLC) System, designed to enhance quality control in laboratories by reducing common errors by up to 40%. This next-generation system integrates with Empower Chromatography Software and eConnect HPLC Columns, promoting operational risk management and productivity. Featuring an intuitive touchscreen for guided operation and system health monitoring, it helps laboratories meet compliance and product delivery goals. The Alliance iS HPLC System will be available starting May 2023.
Waters Corporation (NYSE: WAT) has launched the Battery Cycler Microcalorimeter Solution, enabling unprecedented battery testing capabilities. This advanced device collects six times more data than competitors and reduces validation time for battery safety and performance by up to 75%. The solution allows simultaneous testing of 12 batteries, enhancing efficiency in battery research. With integrated software, researchers can accurately analyze experiments in real-world conditions, optimizing battery development.
Waters Corporation (NYSE:WAT) has ranked fifth on Barron’s 2023 100 Most Sustainable Companies list, marking its third consecutive year on the list and its second in the top ten. The company emphasizes its commitment to environmental, social, and governance (ESG) goals, including reducing its environmental impact and enhancing workforce diversity. Notable achievements in 2022 included the introduction of the Xevo™ TQ Absolute mass spectrometer, which uses 50% less energy and emits less heat, and the opening of a $215 million Precision Chemistry facility in Taunton, Massachusetts, recognized as LEED-certified.
Waters Corporation (NYSE:WAT) announced that its President and CEO, Udit Batra, will take part in a fireside chat at the Cowen Healthcare Conference on March 6, 2023, at 9:50 AM Eastern Time. A live webcast will be accessible via Waters’ investor relations website, and a replay will be available for 30 days after the event. Waters Corporation is a leader in analytical instruments and software, specializing in chromatography, mass spectrometry, and thermal analysis, with over 8,200 employees globally and operations in more than 35 countries.
Waters Corporation (NYSE: WAT) reported fourth-quarter 2022 sales of $859 million, reflecting a 3% increase as reported and 9% in constant currency compared to Q4 2021. The full-year 2022 sales reached $2.97 billion, up 7% as reported and 12% in constant currency. Diluted EPS rose to $3.81 in Q4 2022 from $3.52 in Q4 2021. The company anticipates 2023 organic sales growth of 5% to 6.5% and non-GAAP EPS between $12.55 and $12.75, including a 3% foreign exchange headwind. Additionally, Waters announced the acquisition of Wyatt Technology for $1.36 billion, expected to close in Q2 2023, which will enhance its growth strategy.
FAQ
What is the current stock price of Waters (WAT)?
What is the market cap of Waters (WAT)?
What industries does Waters Corporation serve?
What are some of Waters Corporation's recent product launches?
How does Waters Corporation contribute to scientific advancements?
What is the significance of the TA Instruments Discovery Hybrid Rheometers?
How is Waters Corporation performing financially?
Where is Waters Corporation headquartered?
How many employees does Waters Corporation have?
What are TA Instruments' main products?
What is the significance of the Oasis WAX/GCB Cartridges?
How can I access Waters Corporation's financial results?
